Superworth

Agilent Technologies price to sales ratio A

Market value divided by revenue over the last twelve months, since 2010.

Today, Oct 23, 2026
6.6×
10-year median
5.3×
Against its 10-year history
86th
percentile: 0 is its lowest day, 100 its highest
10-year range
3.4× to 9.1×
Peer median
6.6×

Agilent Technologies' price to sales ratio is 6.6× as of Oct 23, 2026.

That is above its ten-year median of 5.3×, higher than on 86% of days in the last ten years.

Over that time it ranged from 3.4× in Oct 2016 to 9.1× in Aug 2021.

The median for 10 diagnostics and research stocks of a similar size is 6.6×.

Price to sales ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far6.6×4.4×6.6×
20255.6×4.5×6.6×
20245.9×5.6×6.7×
20236.0×4.3×6.8×
20226.5×5.2×7.0×
20217.6×6.4×9.1×
20206.8×3.9×7.0×
20195.1×4.2×5.3×
20184.3×4.1×5.4×
20174.8×3.6×5.1×
20163.5×3.0×3.8×
20153.4×1.8×3.5×
20142.0×1.8×2.1×
20132.0×1.5×2.0×
20121.4×1.3×1.7×
20111.3×1.2×2.3×
20101.9×1.4×2.0×

Against its peers

Companies in Medical - Diagnostics & Research nearest Agilent Technologies' size, closest first, today.

CompanyPrice to sales ratio
AAgilent Technologies6.6×
IQVIQVIA2.7×
WATWaters9.6×
IDXXIDEXX Laboratories9.7×
ILMNIllumina9.1×
MTDMettler-Toledo International8.1×
DGXQuest Diagnostics2.3×
LHLabcorp1.9×
MEDPMedpace6.7×
RVTYRevvity6.1×
DHRDanaher6.5×
Peer median6.6×

Where Agilent Technologies ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Agilent Technologies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.